TITLE:
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1

CONDITION:
Cocaine-Related Disorders

INTERVENTION:
Modafinil

SUMMARY:

      The purpose of this study is to evaluate modafinil, a cocaine treatment medication, and its
      interactions with intravenous (IV) cocaine.
    

DETAILED DESCRIPTION:

      Placebo-controlled, escalating dose drug interaction study using a total of 12 cocaine users
      at a single site. Study duration will include four infusion sessions: 1) screening/baseline;
      2) baseline; 3) 400mg/day steady-state modafinil; 4) 800 mg/day steady state modafinil.
      Infusion session will be 2 days in duration.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 45 Years
Criteria:

        Inclusion Criteria:

        Dependent on cocaine; non-treatment seeking; male or female; DSM-4 criteria for cocaine
        abuse or dependence; at least 18 years of age but no older than 45 non-pregnant females
        using adequate birth control; capable of providing written informed consent; able to
        comply with protocol requirements.

        Exclusion Criteria:

        Additional criteria available during screening at the site
      
